ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 14 filers reported holding ANEBULO PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,395,229 | -4.9% | 511,073 | 0.0% | 0.08% | -2.4% |
| Q1 2024 | $1,466,780 | -40.7% | 511,073 | -50.0% | 0.08% | +13.5% |
| Q4 2023 | $2,473,594 | +58.4% | 1,022,146 | +100.0% | 0.07% | -44.4% |
| Q3 2023 | $1,561,328 | +30.0% | 511,073 | 0.0% | 0.13% | +14.7% |
| Q2 2023 | $1,201,022 | -19.0% | 511,073 | 0.0% | 0.12% | +1.8% |
| Q1 2023 | $1,482,112 | +19.7% | 511,073 | 0.0% | 0.11% | +42.5% |
| Q4 2022 | $1,238,688 | -13.4% | 511,073 | 0.0% | 0.08% | -14.0% |
| Q3 2022 | $1,431,000 | – | 511,073 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,366,290 | $15,401,252 | 13.27% |
| LVW Advisors, LLC | 642,039 | $1,842,652 | 0.31% |
| Nantahala Capital Management | 511,073 | $1,466,780 | 0.08% |
| Ikarian Capital, LLC | 157,862 | $453,064 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $54,467 | 0.00% |
| MORGAN STANLEY | 798,438 | $2,291,518 | 0.00% |
| ROYAL BANK OF CANADA | 38 | $0 | 0.00% |
| VANGUARD GROUP INC | 153,472 | $440,465 | 0.00% |
| WELLS FARGO & COMPANY/MN | 62 | $178 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |